MACSprep™ Chimerism CD34 MicroBead Kit has been developed for the fast isolation of CD34+ cells from freshly drawn anticoagulated whole blood without density gradient centrifugation nor red blood cell lysis.
Related products for MACSprep™ Chimerism CD34 MicroBead Kit, human
MACSprep™ Chimerism CD34 MicroBead Kit has been developed for the fast isolation of CD34+ cells from freshly drawn anticoagulated whole blood without density gradient centrifugation nor red blood cell lysis.
The isolation of CD34+ cells is performed with one labeling step without washing afterwards and in a two-step separation procedure. During the first isolation step red blood cells are aggregated and sedimented. In a second step, CD34+ cells are magnetically labeled with MACSprep Chimerism CD34 MicroBeads. Then, the cell suspension is loaded onto a MACS® Column, which is placed in the magnetic field of a MACS Separator. The magnetically labeled CD34+ cells are retained within the column. The unlabeled cells run through; this cell fraction is thus depleted of CD34+ cells. After removing the column from the magnetic field, the magnetically retained CD34+ cells can be eluted as the positively selected cell fraction.
Protocol overview: Isolation of CD34+ cells from whole blood.
Isolation of CD34+ cells from a whole blood sample from a healthy donor using the MACSprep™ Chimerism CD34 MicroBead Kit, two LS Columns, a MACSmix™ Tube Rotator and a MidiMACS™ Separator. Cells were fluorescently stained with CD34-FITC and CD45-VioBlue® and analyzed by flow cytometry using the MACSQuant® Analyzer X. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. The purity of CD34+ cells after separation is defined by percentage of CD34+ cells (viable CD45dim/+CD34+ cells) amongst leukocytes (viable CD45dim/+ cells). The CD34+ cells content of the isolated fraction with one column is typically around 69.1 ± 5.8% (mean ± SD); 90.8 ± 3.4% (mean ± SD) with two columns. The purity of CD34+ cells varies due to the variation of human samples and experimental set-up.
- de Lapuente Portilla, A. L. et al. (2022) Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels. Blood 139 (11): 1659-1669